Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.

"Disclosure of Potential Conflicts of Interest M.M.'s spouse is a compensated advisor for Orbsen and has compensated shares in Osiris Therapeutics. F.B. is an uncompensated shareholder of Orbsen Therapeutics, Ltd. and Osiris Therapeutics, Inc. The other authors indicated no potential conflicts of interest."

"This work was supported by Science Foundation Ireland (SFI 09/SRC.B1794) and the Irish Research Council (GOIPG/2014/96). This study has also received funding from the European Union's Seventh Framework Programme for Health under grant agreement number 223298. We thank Dr. Gareth Sullivan (Department of Molecular Medicine, Hybrid Technology Hub—Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway & Oslo University Hospital) and Professor James R. Dutton (University of Minnesota) for providing the iPSCs and Dr. Linda Howard (National University of Ireland, Galway) for providing the skin fibroblast for generation of iPSC‐3. We acknowledge the help of Ms. Niamh Duffy, Regenerative Medicine Institute, NUI Galway for her help with cell culture. We also acknowledge the facilities and technical assistance of the Flow Cytometry Facility, the Centre for Microscopy & Imaging (www.imaging.nuigalway.ie)."